Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-383
Closed -$1.38K 6234
2025
Q4
$1.38K Buy
+383
New +$1.59K ﹤0.01% 5508
2025
Q2
Sell
-28
Closed -$4.85K 5823
2025
Q1
$4.85K Buy
+28
New +$5.54K ﹤0.01% 5274
2018
Q1
Hold
0
-$10K 7622
2017
Q4
Sell
-183
Closed -$11.4M 7044
2017
Q3
$16.8M Buy
+183
New +$15.8M 0.01% 884

Other funds holding NCNA

Citigroup's NCNA Position: Q1 2026 in Review

Citigroup sold out of NuCana (NCNA) in Q1 2026, closing a stake of 383 shares — an estimated $1.38K sold.

Citigroup first reported a position in NCNA in Q3 2017 and held it in 3 quarters. The position peaked at $16.8M in Q3 2017. 8 funds tracked by Wall St. Rank hold NCNA as of Q1 2026.

  • Citigroup reported no remaining NuCana position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 383 NuCana shares in Q1 2026, an estimated $1.38K.
  • Citigroup first reported a position in NuCana in Q3 2017 and held it in 3 quarters.
  • Citigroup's NuCana position peaked at $16.8M in Q3 2017.
  • 8 funds tracked by Wall St. Rank held NuCana as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.